Immunological and Inflammatory Biomarkers of Susceptibility and Severity in Adult Respiratory Syncytial Virus Infections
Open Access
- 30 March 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 222 (Supplement), S584-S591
- https://doi.org/10.1093/infdis/jiaa063
Abstract
Respiratory syncytial virus (RSV) is the most common cause of bronchiolitis in young infants. However, it is also a significant pathogen in older adults. Validated biomarkers of RSV disease severity would benefit diagnostics, treatment decisions, and prophylactic interventions. This review summarizes knowledge of biomarkers for RSV disease in adults. A literature review was performed using Ovid Medline, Embase, Global health, Scopus, and Web of Science for articles published 1946–October 2016. Nine articles were identified plus 9 from other sources. From observational studies of natural infection and challenge studies in volunteers, biomarkers of RSV susceptibility or disease severity in adults were: (1) lower anti-RSV neutralizing antibodies, where neutralizing antibody (and local IgA) may be a correlate of susceptibility/severity; (2) RSV-specific CD8+ T cells in bronchoalveolar lavage fluid preinfection (subjects with higher levels had less severe illness); and (3) elevated interleukin-6 (IL-6), IL-8, and myeloperoxidase levels in the airway are indicative of severe infection. Factors determining susceptibility to and severity of RSV disease in adults have not been well defined. Respiratory mucosal antibodies and CD8+ T cells appear to contribute to preventing infection and modulation of disease severity. Studies of RSV pathogenesis in at-risk populations are needed.Keywords
Funding Information
- European Union Horizon 2020 Framework
- European Federation of Pharmaceutical Industries and Associations (116019)
- National Institute for Health Research
This publication has 39 references indexed in Scilit:
- Viral Shedding and Immune Responses to Respiratory Syncytial Virus Infection in Older AdultsThe Journal of Infectious Diseases, 2013
- Vaccine-Elicited CD8 + T Cells Protect against Respiratory Syncytial Virus Strain A2-Line19F-Induced Pathogenesis in BALB/c MiceJournal of Virology, 2012
- Role of Neutralizing Antibodies in Adults With Community-Acquired Pneumonia by Respiratory Syncytial VirusClinical Infectious Diseases, 2012
- Viral Load Drives Disease in Humans Experimentally Infected with Respiratory Syncytial VirusAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Age related changes in T cell mediated immune response and effector memory to Respiratory Syncytial Virus (RSV) in healthy subjectsImmunity & Ageing, 2010
- Risk Factors for Respiratory Failure Associated with Respiratory Syncytial Virus Infection in AdultsThe Journal of Infectious Diseases, 2009
- Serum antibody decay in adults following natural respiratory syncytial virus infectionJournal of Medical Virology, 2006
- The balance between influenza- and RSV-specific CD4 T cells secreting IL-10 or IFNγ in young and healthy-elderly subjectsMechanisms of Ageing and Development, 2005
- Respiratory Syncytial Virus Infection in Elderly and High-Risk AdultsThe New England Journal of Medicine, 2005
- Experimental infection of humans with A2 respiratory syncytial virusAntiviral Research, 2004